Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $1,598,651 were purchased by Melissa Baird on Aug 12 ’25. At $47.96 per share, Melissa Baird acquired 33,333 shares.
Also, Boughton Soleil sold 2,572 shares, netting a total of over 132,818 in proceeds. Following the sale of shares at $51.64 each, the insider now holds 153,021 shares.
Before that, Dudum Andrew had sold 660,000 shares from its account. In a trade valued at $33,384,120, the Chief Executive Officer traded Hims & Hers Health Inc shares for $50.58 each. Upon closing the transaction, the insider’s holdings decreased to 660,000 shares, worth approximately $107.04 million.
As published in a research note from Needham on June 23, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early June. As of April 29, 2025, TD Cowen has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on February 18, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for HIMS stock which previously was a “an Overweight”.
Analyzing HIMS Stock Performance
On last trading session, Hims & Hers Health Inc [NYSE: HIMS] rose 0.77% to $48.33. The stock’s lowest price that day was $46.76, but it reached a high of $48.65 in the same session. During the last five days, there has been a drop of approximately -5.48%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 202.82%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 47.18, which, if violated, would cause prices to drop to 46.02. In the upper region, resistance lies at 49.07. The next price resistance is at 49.80. RSI (Relative Strength Index) is 40.89 on the 14-day chart, showing neutral technical sentiment.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on 2025-07-31 dropping by -3.75 million shares to 64.59 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 68.35 million shares. A decline of -5.81% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.03 of the overall float, the days-to-cover ratio (short ratio) decline to 2.03.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 14.68% from the previous closing price of $47.96. Analysts anticipate Hims & Hers Health Inc stock to reach 68 by 2025, with the lowest price target being 30. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 10, 2025, Citigroup assigned a price target of “a Sell” to the stock and downgraded coverage with a $25.
